IBDEI0LW ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10384,0)
 ;;=378.53^^44^564^16
 ;;^UTILITY(U,$J,358.3,10384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10384,1,3,0)
 ;;=3^Nerve Palsy,Fourth
 ;;^UTILITY(U,$J,358.3,10384,1,4,0)
 ;;=4^378.53
 ;;^UTILITY(U,$J,358.3,10384,2)
 ;;=^265326
 ;;^UTILITY(U,$J,358.3,10385,0)
 ;;=360.01^^44^565^50
 ;;^UTILITY(U,$J,358.3,10385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10385,1,3,0)
 ;;=3^Endophalmitis
 ;;^UTILITY(U,$J,358.3,10385,1,4,0)
 ;;=4^360.01
 ;;^UTILITY(U,$J,358.3,10385,2)
 ;;=Endophalmitis^268545
 ;;^UTILITY(U,$J,358.3,10386,0)
 ;;=V08.^^44^565^53
 ;;^UTILITY(U,$J,358.3,10386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10386,1,3,0)
 ;;=3^HIV Status
 ;;^UTILITY(U,$J,358.3,10386,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,10386,2)
 ;;=HIV Status^303392
 ;;^UTILITY(U,$J,358.3,10387,0)
 ;;=130.2^^44^565^87
 ;;^UTILITY(U,$J,358.3,10387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10387,1,3,0)
 ;;=3^Toxoplasmosis Retinitis
 ;;^UTILITY(U,$J,358.3,10387,1,4,0)
 ;;=4^130.2
 ;;^UTILITY(U,$J,358.3,10387,2)
 ;;=Toxoplasmosis Retinitis^266947
 ;;^UTILITY(U,$J,358.3,10388,0)
 ;;=128.0^^44^565^86
 ;;^UTILITY(U,$J,358.3,10388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10388,1,3,0)
 ;;=3^Toxocariasis
 ;;^UTILITY(U,$J,358.3,10388,1,4,0)
 ;;=4^128.0
 ;;^UTILITY(U,$J,358.3,10388,2)
 ;;=Toxocariasis^120683
 ;;^UTILITY(U,$J,358.3,10389,0)
 ;;=054.42^^44^565^48
 ;;^UTILITY(U,$J,358.3,10389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10389,1,3,0)
 ;;=3^Dendritic Keratitis
 ;;^UTILITY(U,$J,358.3,10389,1,4,0)
 ;;=4^054.42
 ;;^UTILITY(U,$J,358.3,10389,2)
 ;;=Dendritic Keratitis^66763
 ;;^UTILITY(U,$J,358.3,10390,0)
 ;;=370.01^^44^565^65
 ;;^UTILITY(U,$J,358.3,10390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10390,1,3,0)
 ;;=3^Marginal Corneal Ulcer
 ;;^UTILITY(U,$J,358.3,10390,1,4,0)
 ;;=4^370.01
 ;;^UTILITY(U,$J,358.3,10390,2)
 ;;=Marginal Corneal Ulcer^268908
 ;;^UTILITY(U,$J,358.3,10391,0)
 ;;=375.30^^44^565^47
 ;;^UTILITY(U,$J,358.3,10391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10391,1,3,0)
 ;;=3^Dacrocystitis
 ;;^UTILITY(U,$J,358.3,10391,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,10391,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,10392,0)
 ;;=376.01^^44^565^69
 ;;^UTILITY(U,$J,358.3,10392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10392,1,3,0)
 ;;=3^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,10392,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,10392,2)
 ;;=Orbital Cellulitis^259068
 ;;^UTILITY(U,$J,358.3,10393,0)
 ;;=682.0^^44^565^6
 ;;^UTILITY(U,$J,358.3,10393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10393,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,10393,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,10393,2)
 ;;=Cellulitis of Face^271888
 ;;^UTILITY(U,$J,358.3,10394,0)
 ;;=473.9^^44^565^84
 ;;^UTILITY(U,$J,358.3,10394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10394,1,3,0)
 ;;=3^Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,10394,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,10394,2)
 ;;=Sinusitis^123985
 ;;^UTILITY(U,$J,358.3,10395,0)
 ;;=017.30^^44^565^90
 ;;^UTILITY(U,$J,358.3,10395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10395,1,3,0)
 ;;=3^Tuberculosis,Eye
 ;;^UTILITY(U,$J,358.3,10395,1,4,0)
 ;;=4^017.30
 ;;^UTILITY(U,$J,358.3,10395,2)
 ;;=^122722
 ;;^UTILITY(U,$J,358.3,10396,0)
 ;;=076.9^^44^565^88
 ;;^UTILITY(U,$J,358.3,10396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10396,1,3,0)
 ;;=3^Trachoma,Unspec
 ;;^UTILITY(U,$J,358.3,10396,1,4,0)
 ;;=4^076.9
 ;;^UTILITY(U,$J,358.3,10396,2)
 ;;=^120805
 ;;^UTILITY(U,$J,358.3,10397,0)
 ;;=077.0^^44^565^31
 ;;^UTILITY(U,$J,358.3,10397,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0LW
